$1.5
Live
2.0%
Downside
Day's Volatility :6.37%
Upside
4.46%
33.33%
Downside
52 Weeks Volatility :91.45%
Upside
87.18%
Period | Intelligent Bio Solutions Inc | Index (Russel 2000) |
---|---|---|
3 Months | 13.77% | 0.0% |
6 Months | -40.98% | 0.0% |
1 Year | -45.94% | 0.0% |
3 Years | -98.61% | -23.0% |
Market Capitalization | 6.2M |
Book Value | $2.41 |
Earnings Per Share (EPS) | -6.38 |
Wall Street Target Price | 12.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -386.32% |
Return On Assets TTM | -53.26% |
Return On Equity TTM | -171.71% |
Revenue TTM | 3.1M |
Revenue Per Share TTM | 1.95 |
Quarterly Revenue Growth YOY | 64.2% |
Gross Profit TTM | 326.7K |
EBITDA | -9.3M |
Diluted Eps TTM | -6.38 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 700.0%
Sell
Neutral
Buy
Intelligent Bio Solutions Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Intelligent Bio Solutions Inc | -8.72% | -40.98% | -45.94% | -98.61% | -98.61% |
Stryker Corporation | 0.83% | 12.78% | 40.21% | 33.69% | 71.83% |
Boston Scientific Corp. | 4.85% | 29.48% | 75.68% | 96.28% | 127.87% |
Edwards Lifesciences Corp. | 4.32% | -19.19% | 1.77% | -39.29% | -7.22% |
Abbott Laboratories | 3.99% | 11.51% | 24.65% | -4.53% | 46.22% |
Medtronic Plc | 2.65% | 14.48% | 27.42% | -24.18% | -13.49% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Intelligent Bio Solutions Inc | 0.04 | NA | NA | 0.0 | -1.72 | -0.53 | NA | 2.41 |
Stryker Corporation | 40.15 | 40.15 | 2.64 | 12.01 | 0.19 | 0.07 | 0.01 | 51.86 |
Boston Scientific Corp. | 70.26 | 70.26 | 2.14 | 2.41 | 0.09 | 0.05 | NA | 13.85 |
Edwards Lifesciences Corp. | 27.67 | 27.67 | 3.65 | 2.6 | 0.22 | 0.12 | NA | 12.35 |
Abbott Laboratories | 35.83 | 35.83 | 4.31 | 4.67 | 0.14 | 0.06 | 0.02 | 22.26 |
Medtronic Plc | 30.23 | 30.23 | 1.67 | 5.2 | 0.08 | 0.04 | 0.03 | 37.39 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Intelligent Bio Solutions Inc | Buy | $6.2M | -98.61% | 0.04 | 0.0% |
Stryker Corporation | Buy | $137.1B | 71.83% | 40.15 | 16.12% |
Boston Scientific Corp. | Buy | $127.3B | 127.87% | 70.26 | 12.0% |
Edwards Lifesciences Corp. | Buy | $42.3B | -7.22% | 27.67 | 23.74% |
Abbott Laboratories | Buy | $205.1B | 46.22% | 35.83 | 13.65% |
Medtronic Plc | Buy | $115.2B | -13.49% | 30.23 | 12.06% |
Insights on Intelligent Bio Solutions Inc
Revenue is down for the last 2 quarters, 823.8K → 727.82K (in $), with an average decrease of 11.7% per quarter
Netprofit is up for the last 2 quarters, -2.97M → -2.78M (in $), with an average increase of 7.1% per quarter
In the last 1 year, Boston Scientific Corp. has given 76.0% return, outperforming this stock by 127.5%
ADAR1 Capital Management LLC
Altium Capital Management, LP
CVI Holdings LLC
Geode Capital Management, LLC
Vanguard Group Inc
UBS Group AG
Organization | Intelligent Bio Solutions Inc |
Employees | 50 |
CEO | Mr. Harry Simeonidis |
Industry | Miscellaneous |
Jpmorgan Betabuilders 1-5 Year Us Aggregate Bd Etf
$1.50
-4.46%
Invesco Bulletshares 2025 Hi
$1.50
-4.46%
Schwab International Dividend Equity Etf
$1.50
-4.46%
Innovator Intl Developed 10 Buffer Etf - Quarterly
$1.50
-4.46%
Lightpath Technologies Inc
$1.50
-4.46%
Vaneck Vectors Global Alternative Energy Etf
$1.50
-4.46%
First Trust Flexible Municipal High Income Etf
$1.50
-4.46%
Drx Dly Reg Bank Bull 3x
$1.50
-4.46%
Graniteshares 2x Long Pltr Daily Etf
$1.50
-4.46%